RT Journal Article
SR Electronic
T1 Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 1690
OP 1693
DO 10.1097/IGC.0000000000000823
VO 26
IS 9
A1 David Gaffney
A1 Bill Small
A1 Henry Kitchener
A1 Sang Young Ryu
A1 Akila Viswanathan
A1 Ted Trimble
A1 Al Covens
A1 Sarikapan Wilailak
A1 Arb-aroon Lertkhachonsuk
A1 Chomporn Sitathanee
A1 Umesh Mahantshetty
A1 Brandon Fisher
A1 Susan Springer
A1 Thomas Pollatz
A1 Antonius Spiller
A1 Monica Bacon
A1 Anuja Jhingran
YR 2016
UL http://ijgc.bmj.com/content/26/9/1690.abstract
AB Abstract Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.